Sphera Funds Management Ltd. Biogen Inc. Transaction History

Sphera Funds Management Ltd.

$683 Million
Q2 2024

A detailed history of Sphera Funds Management Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 47,412 shares of BIIB stock, worth $8.24 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

47,412

Previous 70,646 32.89%

Holding current value

$8.24 Million

Previous $15.2 Million 27.85%

% of portfolio

1.61%

Previous 2.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $4.43 Million - $5.5 Million	-23,234 Reduced 32.89%	47,412 $11 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $5.15 Million - $6.51 Million	24,300 Added 52.43%	70,646 $15.2 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $4.56 Million - $5.49 Million	20,500 Added 79.32%	46,346 $12 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $506,600 - $571,780	2,000 Added 8.39%	25,846 $6.64 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $2.66 Million - $3.08 Million	-9,670 Reduced 28.85%	23,846 $6.79 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $6.67 Million - $7.6 Million	26,000 Added 345.93%	33,516 $9.32 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $12.1 Million - $14.7 Million	-47,984 Reduced 86.46%	7,516 $2.08 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $10.8 Million - $14.9 Million	55,500 New	55,500 $14.8 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $2.52 Million - $3.17 Million	-13,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2.46 Million - $3.16 Million	-10,995 Reduced 45.82%	13,000 $3.12 Million
Q2 2021 Aug 17, 2021	BUY	$259.0 - $414.71 $4.45 Million - $7.13 Million	17,195 Added 252.87%	23,995 $8.31 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $5.64 Million - $6.6 Million	-23,200 Reduced 77.33%	6,800 $1.9 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $6.5 Million - $10.2 Million	30,000 New	30,000 $7.09 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $14.7 Million - $19.2 Million	-50,000 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $3.86 Million - $4.6 Million	-15,000 Reduced 23.08%	50,000 $14.5 Million
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $2.39 Million - $3.38 Million	-9,200 Reduced 12.4%	65,000 $17.8 Million
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $9.48 Million - $10.6 Million	-30,800 Reduced 29.33%	74,200 $23.6 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $29.5 Million - $34.6 Million	105,000	105,000 $32.9 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Biogen Inc. Transaction History